Skip to content

Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea

A Double-blind, Randomized, Placebo-controlled Clinical Trial (Pilot Phase) to Evaluate the Efficacy of a Medical Nutrition Product, PTM202, in Children With Acute Diarrhea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01814202
Enrollment
68
Registered
2013-03-19
Start date
2013-03-31
Completion date
2013-09-30
Last updated
2013-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Diarrhea

Brief summary

The purpose of this study is to determine whether a medical nutrition product, PTM202, along with standard of care, enhances recovery and reduces diarrhea morbidity in young children

Interventions

OTHERPTM202
OTHERPlacebo

Sponsors

PanTheryx, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* males or females between 6 months and 5 years of age * acute diarrhea (\<48 hours) without interfering co-morbidities * guardian willing to have child admitted to hospital as an inpatient for 96 hours and to return to the clinic with the child on Day 7 for a final evaluation * Guardian is willing and able to report to the Investigator information on stool frequency, stool consistency and food and water intakes during the follow up phase. * Written informed consent must be obtained prior to admission to this study. * The subject has a physical examination that reveals no clinically significant abnormalities other than those expected for subjects with acute infectious diarrhea.

Exclusion criteria

* Suspected or confirmed cholera * Suspected dysentery * Symptom duration \>48 hours at screening * Vomiting severity that is like to make administration and retention of test article impossible * Severe malnutrition (defined as weight for height of less than -3 SD below median, per WHO Standards (6). * Child already receiving antibiotics or anti-motility drugs for this diarrhea episode prior to screening. * History of hypersensitivity or allergy to milk or egg

Design outcomes

Primary

MeasureTime frame
diarrhea duration7 days

Secondary

MeasureTime frame
food intake7 days
stool frequency7 days
stool consistency7 days

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026